What to expect from CAR T-cell therapy for lymphoma

A specialist team first reviews the lymphoma type, previous treatments, current health, blood tests, scans, infections, and medicines. T cells are then collected from your blood and sent for modification so they can target lymphoma cells. While the cells are being prepared, your doctors may discuss temporary treatment to control the lymphoma.

Short conditioning chemotherapy is usually given before the modified cells return. The CAR T-cell infusion uses an intravenous line. The following days are closely supervised because immune activation may cause fever, low blood pressure, breathing changes, or neurological symptoms. Blood counts can also fall, increasing the need for infection precautions and follow-up.

Plan for a caregiver, reliable transport, and regular contact with the treatment centre. Bring an updated list of medicines and report infection symptoms before treatment begins. Once home, measure your temperature as instructed, take prescribed medicines, keep follow-up appointments, and avoid driving until your clinicians approve it. Rest is useful, but follow the team’s advice about gentle movement and hydration.

Ask how long you should stay close to the centre and who to call outside clinic hours. Keep your discharge instructions accessible, and tell every healthcare professional that you recently received CAR T-cell therapy.

Call the treatment centre urgently for fever, shaking chills, shortness of breath, chest discomfort, faintness, worsening weakness, confusion, difficulty finding words, unusual drowsiness, tremor, or seizure. These symptoms can change quickly, so use the emergency route given by your team rather than waiting for routine review.

Ask why CAR T-cell therapy is being considered, what the collection timetable is, whether bridging treatment is needed, what support is available for side effects, how follow-up scans and blood tests are arranged, and when normal activities may resume.